Eleanor Ramos

Eleanor Ramos

Directeur Technique/Scientifique/R&D chez PROVENTION BIO, INC.
69 ans
Health Technology
Consumer Services
Commercial Services

Profil

Eleanor Leni Ramos is currently the Director at Ask About Lung Cancer, Inc. and the Chief Medical Officer at Provention Bio, Inc. Previously, she held positions such as Director-Renal Transplant Services at The Brigham & Women's Hospital, Inc. and the University of Florida, Director-Clinical Research at Roche Global Development, and Executive Director-Clinical Trials Group at Immune Tolerance Network.
She also served as Vice President-Global Clinical Research at Bristol Myers Squibb Co. and Chief Medical Officer & Senior Vice President at ZymoGenetics, Inc. Additionally, she was the Chief Medical Officer at Theraclone Sciences, Inc. and Global Blood Therapeutics, Inc. Dr. Ramos obtained her undergraduate and doctorate degrees from Tufts University.

Postes actifs de Eleanor Ramos

SociétésPosteDébut
PROVENTION BIO, INC. Directeur Technique/Scientifique/R&D 01/06/2017
Directeur/Membre du Conseil -

Anciens postes connus de Eleanor Ramos

SociétésPosteFin
GLOBAL BLOOD THERAPEUTICS, INC. Directeur Technique/Scientifique/R&D 24/10/2016
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 01/12/2006
Corporate Officer/Principal -
Corporate Officer/Principal -
Roche Global Development
Corporate Officer/Principal -
Voir l'expérience en détail de Eleanor Ramos

Formation de Eleanor Ramos

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

67

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Health Services

Consumer Services

Consumer Services

Roche Global Development

Commercial Services

Health Technology

Health Technology

Commercial Services

  1. Bourse
  2. Insiders
  3. Eleanor Ramos
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT